Bargude Balta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Bargude Balta has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
Amanuel Fanta Lambebo
3 shared publicationsDejene Hailu
2 shared publicationsGulema Demissie
Affiliation Hawassa University College of Medicine and Health Sciences, Hawassa, Ethiopia
2 shared publicationsAbel Hailu
Addis Ababa University College of Medicine and Health Sciences Addis Ababa Ethiopia
1 shared publication- Abel Wubu
Addis Ababa university college of health science, Addis Ababa, Ethiopia
1 shared publication Abreham Kassahun
Addis Ababa University College of Medicine and Health Sciences Addis Ababa Ethiopia
1 shared publication
Latest Publications
- Open Access
- 16 October 2026
- Published by Wiley in Cancer Reports
- Vol. 9 (10) , e70722
Survival Status and Predictors of Mortality Among Women With Breast Cancer in Southern Ethiopia: A Retrospective Cohort Study
Introduction: Breast cancer continues to be a leading cause of morbidity and mortality worldwide, with an especially severe impact in low‐resource settings. In such contexts, delayed diagnosis, limited diagnostic capacity, and inadequate access to treatment contribute to poor survival outcomes. However, little is known about how these factors influence survival patterns specifically in southern Ethiopia, highlighting the need for locally generated data to guide interventions. Methodology: A hospital‐based retrospective cohort study was conducted among 507 breast cancer patients attending selected hospitals in southern Ethiopia. Data were collected by two trained BSc nurses using an Open Data Kit (ODK) tool. Descriptive statistics were presented using tables and graphs, while bivariable, and multivariable Cox regression models were used to identify independent predictors of survival. Results: A total of 507 medical records were reviewed, of which 492 eligible women were included in the final analysis. The overall survival rates were 54.5% at 2 years and 23.9% at 3 years. In multivariable Cox regression analysis, advanced stage had a higher hazard of death (AHR = 1.73, 95% CI: 1.19–2.51). Poor NPI was also associated with increased mortality (AHR = 2.30, 95% CI: 1.50–5.10). Patients with an NLR < 3 had a lower hazard of death (AHR = 0.68, 95% CI: 0.47–0.97), as did those who received hormonal therapy (AHR = 0.64, 95% CI: 0.44–0.92). Conclusion: Advanced‐stage disease and poorer NPI were associated with a higher hazard of death from any cause, while lower NLR and hormonal therapy were associated with better overall survival. Strengthening early diagnosis and ensuring appropriate treatment may improve overall survival among women with breast cancer in resource‐constrained settings.
- 16 October 2026
- Published by Wiley in Cancer Reports
- Vol. 9 (10) , e70722
Open AccessSurvival Status and Predictors of Mortality Among Women With Breast Cancer in Southern Ethiopia: A Retrospective Cohort Study
Introduction: Breast cancer continues to be a leading cause of morbidity and mortality worldwide, with an especially severe impact in low‐resource settings. In such contexts, delayed diagnosis, limited diagnostic capacity, and inadequate access to treatment contribute to poor survival outcomes. However, little is known about how these factors influence survival patterns specifically in southern Ethiopia, highlighting the need for locally generated data to guide interventions. Methodology: A hospital‐based retrospective cohort study was conducted among 507 breast cancer patients attending selected hospitals in southern Ethiopia. Data were collected by two trained BSc nurses using an Open Data Kit (ODK) tool. Descriptive statistics were presented using tables and graphs, while bivariable, and multivariable Cox regression models were used to identify independent predictors of survival. Results: A total of 507 medical records were reviewed, of which 492 eligible women were included in the final analysis. The overall survival rates were 54.5% at 2 years and 23.9% at 3 years. In multivariable Cox regression analysis, advanced stage had a higher hazard of death (AHR = 1.73, 95% CI: 1.19–2.51). Poor NPI was also associated with increased mortality (AHR = 2.30, 95% CI: 1.50–5.10). Patients with an NLR < 3 had a lower hazard of death (AHR = 0.68, 95% CI: 0.47–0.97), as did those who received hormonal therapy (AHR = 0.64, 95% CI: 0.44–0.92). Conclusion: Advanced‐stage disease and poorer NPI were associated with a higher hazard of death from any cause, while lower NLR and hormonal therapy were associated with better overall survival. Strengthening early diagnosis and ensuring appropriate treatment may improve overall survival among women with breast cancer in resource‐constrained settings.
- Open Access
- 24 September 2026
- Published by Ecancer Global Foundation in ecancermedicalscience
- Vol. 20
Determinants of delayed treatment initiation among patients with colorectal cancer at Hawassa University Comprehensive Specialized Hospital, Sidama Region, southern Ethiopia: a retrospective study
Determinants of delayed treatment initiation among patients with colorectal cancer at Hawassa University Comprehensive Specialized Hospital, Sidama Region, so
- 24 September 2026
- Published by Ecancer Global Foundation in ecancermedicalscience
- Vol. 20
Open AccessDeterminants of delayed treatment initiation among patients with colorectal cancer at Hawassa University Comprehensive Specialized Hospital, Sidama Region, southern Ethiopia: a retrospective study
Determinants of delayed treatment initiation among patients with colorectal cancer at Hawassa University Comprehensive Specialized Hospital, Sidama Region, so
- Open Access
- 16 July 2026
- Published by Elsevier in Cancer Treatment and Research Communications
- Vol. 48, 101322
Gaps in awareness, misconceptions, and cultural barriers to breast cancer care: community and stakeholder perspectives from Southern Ethiopia: a qualitative study
- 16 July 2026
- Published by Elsevier in Cancer Treatment and Research Communications
- Vol. 48, 101322
Open AccessGaps in awareness, misconceptions, and cultural barriers to breast cancer care: community and stakeholder perspectives from Southern Ethiopia: a qualitative study
- Open Access
- 2 July 2026
- Published by Springer Nature in BMC Cancer
- Vol. 26 (1)
Catastrophic health expenditure and its determinant factors among patients with cancer attending Wolaita Sodo University Comprehensive Specialized Hospital, South Ethiopia
Cancer patients often face catastrophic health expenditures (CHE), leading to significant financial burdens for households. When cancer treatment depends m
- 2 July 2026
- Published by Springer Nature in BMC Cancer
- Vol. 26 (1)
Open AccessCatastrophic health expenditure and its determinant factors among patients with cancer attending Wolaita Sodo University Comprehensive Specialized Hospital, South Ethiopia
Cancer patients often face catastrophic health expenditures (CHE), leading to significant financial burdens for households. When cancer treatment depends m
- Open Access
- 14 October 2025
- Published by Wiley in Clinical Case Reports
- Vol. 13 (10)
Bilateral Adrenal Mass Secondary to Bilateral Infantile Neuroblastoma in an Infant With Beckwith‐Wiedemann Syndrome
Infants with Beckwith‐Wiedemann syndrome face a high risk of embryonal tumors, necessitating early and consistent surveillance. This case illustrates how timely imaging and biochemical monitoring enabled successful non‐surgical management of bilateral adrenal neuroblastoma. Multidisciplinary care and structured follow‐up are essential to ensure early detection, effective treatment, and favorable outcomes.
- 14 October 2025
- Published by Wiley in Clinical Case Reports
- Vol. 13 (10)
Open AccessBilateral Adrenal Mass Secondary to Bilateral Infantile Neuroblastoma in an Infant With Beckwith‐Wiedemann Syndrome
Infants with Beckwith‐Wiedemann syndrome face a high risk of embryonal tumors, necessitating early and consistent surveillance. This case illustrates how timely imaging and biochemical monitoring enabled successful non‐surgical management of bilateral adrenal neuroblastoma. Multidisciplinary care and structured follow‐up are essential to ensure early detection, effective treatment, and favorable outcomes.
- Open Access
- 30 May 2025
- Published by Springer Nature in BMC Women's Health
- Vol. 25 (1) , 1-9
Women’s satisfaction with health extension services and its associated factors in Hawassa City, Sidama region, Southern Ethiopia
Maternal health services were among the services provided by health extension workers, but the utilization of these services remains inadequate in Ethiopia. Therefore, this study aimed to study women’s satisfaction and related factors with health extension service in Hawassa City, Sidama region, Southern Ethiopia. This study aimed to assess women’s satisfaction with health services provided by health extension workers and its associated factors in Hawassa City. A community-based cross-sectional study was conducted from August 1/2022 – September 1/2022 in Hawassa city. A multistage sampling technique was used to allocate 363 study participants. Data were checked for completeness and consistency, then, coded and entered into Epidata version 4.6, exported to the SPSS, IBM version 26. Descriptive statistics was used to describe the study variables. In the bivariable analysis, variables with P-Value < 0.25 were considered candidates for multivariable analysis, and significance was declared at P-Value < 0.05. From 355 samples, 353 women participated in the survey with a 99% response rate. The overall proportion of women satisfied with health extension services was 51.8% with a 95% CI (46.9–56.8%). Two hundred fifty-nine (73.4%) of mothers used family planning services and 248(70.3%) participants were exposed to Maternal and child health services. Above secondary education AOR = 2.4; 95% CI (1.1–5.1), Husband occupation AOR = 15; 95% CI:7–33) and being model family AOR = 2.43; 95% CI:1.02–5.6) had higher odds of satisfaction with health extension services. In the research area, women’s satisfaction with health extension services was low compared to other national studies. A husband’s job, having a better education, and being a model household were all positively correlated with their level of satisfaction. To maximize women’s satisfaction training and certifying model households was essential.
- 30 May 2025
- Published by Springer Nature in BMC Women's Health
- Vol. 25 (1) , 1-9
Open AccessWomen’s satisfaction with health extension services and its associated factors in Hawassa City, Sidama region, Southern Ethiopia
Maternal health services were among the services provided by health extension workers, but the utilization of these services remains inadequate in Ethiopia. Therefore, this study aimed to study women’s satisfaction and related factors with health extension service in Hawassa City, Sidama region, Southern Ethiopia. This study aimed to assess women’s satisfaction with health services provided by health extension workers and its associated factors in Hawassa City. A community-based cross-sectional study was conducted from August 1/2022 – September 1/2022 in Hawassa city. A multistage sampling technique was used to allocate 363 study participants. Data were checked for completeness and consistency, then, coded and entered into Epidata version 4.6, exported to the SPSS, IBM version 26. Descriptive statistics was used to describe the study variables. In the bivariable analysis, variables with P-Value < 0.25 were considered candidates for multivariable analysis, and significance was declared at P-Value < 0.05. From 355 samples, 353 women participated in the survey with a 99% response rate. The overall proportion of women satisfied with health extension services was 51.8% with a 95% CI (46.9–56.8%). Two hundred fifty-nine (73.4%) of mothers used family planning services and 248(70.3%) participants were exposed to Maternal and child health services. Above secondary education AOR = 2.4; 95% CI (1.1–5.1), Husband occupation AOR = 15; 95% CI:7–33) and being model family AOR = 2.43; 95% CI:1.02–5.6) had higher odds of satisfaction with health extension services. In the research area, women’s satisfaction with health extension services was low compared to other national studies. A husband’s job, having a better education, and being a model household were all positively correlated with their level of satisfaction. To maximize women’s satisfaction training and certifying model households was essential.
- Open Access
- 19 April 2025
- Published by Springer Nature in Journal of Health, Population and Nutrition
- Vol. 44 (1) , 1-11
Survival status and predictors of mortality among children with severe acute malnutrition admitted to public health facilities at Hawassa City, Southern Ethiopia: a retrospective cohort study
Despite improvements in child health and nutrition in Ethiopia, undernutrition remains a critical issue, causing half of child deaths. Many severely malnourished children seek treatment at therapeutic feeding centers, but a significant number still die in stabilization centers. This study aimed to estimate survival rates and identify predictors of mortality among children with severe acute malnutrition admitted to public health facilities in Hawassa City, Southern Ethiopia. The main aim of this study was to estimate survival status and predictors of mortality among children with severe acute malnutrition admitted to public health facilities at Hawassa City, Southern Ethiopia. A facility-based retrospective cohort study was employed to estimate survival status and predictors among under-five children with severe acute malnutrition admitted to selected health facilities. A total of 476 randomly selected under-five children with SAM from January 2018 to December 31, 2021, participated in the study. Data were analyzed by SPSS IBM version 26. Bivariable and multivariable Cox regression models assessed risk factors. Kaplan- Maier Curve and Long rank test were used to estimate cumulative survival probability and to compare survival status probability across different groups. Over the 3-year observation period, the overall survival status was, (84.7%), [95% CI; 81.2, 87.8]. The incidence density of death was 3.8/100 person-day. The overall median survival time was 34 [95% CI 32.2–37.5] days. After controlling for other factors, a child who had co-morbidities [AHR = 3.305, 95%; CI: (1.1, 10.9)], and Albendazole [AHR = 5.3, 95%; CI: (1.3, 21.7)] were identified as the independent predictors of the time to death. The findings of this study confirm the mortality rate was higher than in most national studies. A significantly low recovery rate was identified for the children with co-morbidities and those who had not been dewormed. Expanding the immunization programs and deworming programs regularly which link nutrition interventions was recommended to raise the recovery rate.
- 19 April 2025
- Published by Springer Nature in Journal of Health, Population and Nutrition
- Vol. 44 (1) , 1-11
Open AccessSurvival status and predictors of mortality among children with severe acute malnutrition admitted to public health facilities at Hawassa City, Southern Ethiopia: a retrospective cohort study
Despite improvements in child health and nutrition in Ethiopia, undernutrition remains a critical issue, causing half of child deaths. Many severely malnourished children seek treatment at therapeutic feeding centers, but a significant number still die in stabilization centers. This study aimed to estimate survival rates and identify predictors of mortality among children with severe acute malnutrition admitted to public health facilities in Hawassa City, Southern Ethiopia. The main aim of this study was to estimate survival status and predictors of mortality among children with severe acute malnutrition admitted to public health facilities at Hawassa City, Southern Ethiopia. A facility-based retrospective cohort study was employed to estimate survival status and predictors among under-five children with severe acute malnutrition admitted to selected health facilities. A total of 476 randomly selected under-five children with SAM from January 2018 to December 31, 2021, participated in the study. Data were analyzed by SPSS IBM version 26. Bivariable and multivariable Cox regression models assessed risk factors. Kaplan- Maier Curve and Long rank test were used to estimate cumulative survival probability and to compare survival status probability across different groups. Over the 3-year observation period, the overall survival status was, (84.7%), [95% CI; 81.2, 87.8]. The incidence density of death was 3.8/100 person-day. The overall median survival time was 34 [95% CI 32.2–37.5] days. After controlling for other factors, a child who had co-morbidities [AHR = 3.305, 95%; CI: (1.1, 10.9)], and Albendazole [AHR = 5.3, 95%; CI: (1.3, 21.7)] were identified as the independent predictors of the time to death. The findings of this study confirm the mortality rate was higher than in most national studies. A significantly low recovery rate was identified for the children with co-morbidities and those who had not been dewormed. Expanding the immunization programs and deworming programs regularly which link nutrition interventions was recommended to raise the recovery rate.
- Open Access
- 7 April 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (4) , e0321306
Adherence to intravenous chemotherapy and associated factors among patients with cancer at Hawassa University Comprehensive Specialized Hospital Cancer Treatment Center, Sidama Region, Southern Ethiopia
Background: Medication adherence refers to how closely a patient follows the prescribed timing and dosage of their treatment. Adherence to chemotherapy is particularly complex and multifaceted, and it can have a significant impact on the effectiveness of the therapy. In Ethiopia, non-adherence to chemotherapy is on the rise, but there has been limited research specifically on adherence to intravenous (IV) chemotherapy. Objective: This study assesses IV chemotherapy adherence and associated factors among cancer patients in the Sidama Region, southern Ethiopia. Methods: A hospital-based cross-sectional study included a purposive sample of 413 cancer patients undergoing IV chemotherapy. The Morisky Medication Adherence Scale was used to measure adherence levels. Data analysis was performed using SPSS version 26, employing descriptive statistics such as frequency distribution, mean, median, and standard deviation to describe the characteristics and magnitude of IV chemotherapy adherence. Bivariable and multivariable logistical regression analysis was conducted to identify factors associated with IV chemotherapy adherence. Result: The current study revealed that the overall magnitude of good adherence toward chemotherapy treatment among cancer patients was 176/413(42.6%), with a 95% CI of 38–47.9. The multivariable analysis identified several independent factors associated with IV chemotherapy adherence. These factors included being married (AOR = 3.2, 95% CI:1.3,8), employment as a government employee (AOR = 2.4,95% CI:1.3,4.5), availability of transportation (AOR = 5.5, 95% CI:2.1,14), Good social support (AOR = 2.1,95% CI:1.9,11.3) and having a curative goal of treatment (AOR = 1.7,95% CI:1.1,2.7). Conclusion: In the current study, the magnitude of intravenous chemotherapy adherence among patients with cancer was low compared to published national and international findings. Possible contributing factors include marital status, employment, Transportation availability, and social support. Targeted measures are needed to improve adherence and, as a result, maximize therapeutic benefits.
- 7 April 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (4) , e0321306
Open AccessAdherence to intravenous chemotherapy and associated factors among patients with cancer at Hawassa University Comprehensive Specialized Hospital Cancer Treatment Center, Sidama Region, Southern Ethiopia
Background: Medication adherence refers to how closely a patient follows the prescribed timing and dosage of their treatment. Adherence to chemotherapy is particularly complex and multifaceted, and it can have a significant impact on the effectiveness of the therapy. In Ethiopia, non-adherence to chemotherapy is on the rise, but there has been limited research specifically on adherence to intravenous (IV) chemotherapy. Objective: This study assesses IV chemotherapy adherence and associated factors among cancer patients in the Sidama Region, southern Ethiopia. Methods: A hospital-based cross-sectional study included a purposive sample of 413 cancer patients undergoing IV chemotherapy. The Morisky Medication Adherence Scale was used to measure adherence levels. Data analysis was performed using SPSS version 26, employing descriptive statistics such as frequency distribution, mean, median, and standard deviation to describe the characteristics and magnitude of IV chemotherapy adherence. Bivariable and multivariable logistical regression analysis was conducted to identify factors associated with IV chemotherapy adherence. Result: The current study revealed that the overall magnitude of good adherence toward chemotherapy treatment among cancer patients was 176/413(42.6%), with a 95% CI of 38–47.9. The multivariable analysis identified several independent factors associated with IV chemotherapy adherence. These factors included being married (AOR = 3.2, 95% CI:1.3,8), employment as a government employee (AOR = 2.4,95% CI:1.3,4.5), availability of transportation (AOR = 5.5, 95% CI:2.1,14), Good social support (AOR = 2.1,95% CI:1.9,11.3) and having a curative goal of treatment (AOR = 1.7,95% CI:1.1,2.7). Conclusion: In the current study, the magnitude of intravenous chemotherapy adherence among patients with cancer was low compared to published national and international findings. Possible contributing factors include marital status, employment, Transportation availability, and social support. Targeted measures are needed to improve adherence and, as a result, maximize therapeutic benefits.
- Open Access
- 26 August 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (8) , e0304820
Survival and predictors of mortality among colorectal cancer patients on follow-up in Hawassa University Comprehensive Specialized Hospital, Sidama region, Southern Ethiopia, 2022. A 5-year retrospective cohort study
Background: The incidence and mortality of colorectal cancer were still rising rapidly in many low-income and middle-income countries, which was linked to ongoing societal and economic status. Colorectal cancer is the leading cancer in Ethiopia with relatively lower survival. However, colorectal cancer patients’ survival time and predictors have not been well studied in Southern Ethiopia. Objective: This study aimed to assess five-year survival and predictors of mortality among colorectal cancer patients at Hawassa Comprehensive Specialized Hospital, Ethiopia. Method: Facility-based retrospective cohort study was conducted among 323 patients who visited Hawassa Comprehensive Specialized Hospital from May 1st, 2017 to April 30th, 2022. The Kaplan-Meier survival curve with the Log-rank test was used to estimate the survival time. Bivariable and multivariable Cox proportional hazards regression models were used to determine the net effect of each independent variable on time to death after diagnosis. Result: Over the 5-year observation period, the overall mortality rate was 38.5%, with an incidence density of 31 fatalities per 100 person-years observation. Survival at 1, 2, 3, 4, and 5 years was 78%, 53, 32.4%, 23.3%, and 18.7% respectively. The multivariable analysis showed that metastatic disease (AHR = 4.2, CI: 1.5–11.5), baseline carcinoembryonic antigen level ≥5ng/ml (AHR: 2.4, CI: 1.2–5.8), living in rural areas (AHR = 2.2, CI:1.03–4.8) and mucinous carcinoma (AHR = 0.33, CI: 0.13–0.87) were independent predictors of colorectal cancer mortality. Conclusion: Overall survival of colorectal cancer patients in the study was low compared to similar studies in developing and developed worlds. A significantly low survival rate was observed for patients with advanced stage, elevated carcinoembryonic antigen levels, and rural residents indicating the key role of early detection and timely initiation of treatment to improve survival and quality of life of patients with colorectal cancer.
- 26 August 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (8) , e0304820
Open AccessSurvival and predictors of mortality among colorectal cancer patients on follow-up in Hawassa University Comprehensive Specialized Hospital, Sidama region, Southern Ethiopia, 2022. A 5-year retrospective cohort study
Background: The incidence and mortality of colorectal cancer were still rising rapidly in many low-income and middle-income countries, which was linked to ongoing societal and economic status. Colorectal cancer is the leading cancer in Ethiopia with relatively lower survival. However, colorectal cancer patients’ survival time and predictors have not been well studied in Southern Ethiopia. Objective: This study aimed to assess five-year survival and predictors of mortality among colorectal cancer patients at Hawassa Comprehensive Specialized Hospital, Ethiopia. Method: Facility-based retrospective cohort study was conducted among 323 patients who visited Hawassa Comprehensive Specialized Hospital from May 1st, 2017 to April 30th, 2022. The Kaplan-Meier survival curve with the Log-rank test was used to estimate the survival time. Bivariable and multivariable Cox proportional hazards regression models were used to determine the net effect of each independent variable on time to death after diagnosis. Result: Over the 5-year observation period, the overall mortality rate was 38.5%, with an incidence density of 31 fatalities per 100 person-years observation. Survival at 1, 2, 3, 4, and 5 years was 78%, 53, 32.4%, 23.3%, and 18.7% respectively. The multivariable analysis showed that metastatic disease (AHR = 4.2, CI: 1.5–11.5), baseline carcinoembryonic antigen level ≥5ng/ml (AHR: 2.4, CI: 1.2–5.8), living in rural areas (AHR = 2.2, CI:1.03–4.8) and mucinous carcinoma (AHR = 0.33, CI: 0.13–0.87) were independent predictors of colorectal cancer mortality. Conclusion: Overall survival of colorectal cancer patients in the study was low compared to similar studies in developing and developed worlds. A significantly low survival rate was observed for patients with advanced stage, elevated carcinoembryonic antigen levels, and rural residents indicating the key role of early detection and timely initiation of treatment to improve survival and quality of life of patients with colorectal cancer.
- Open Access
- 2 October 2023
- Published by Wiley in Cancer Reports
- Vol. 6 (10) , e1890
Survival and predictors of mortality among acute leukemia patients on follow‐up in Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia: A 5‐year retrospective cohort study
Background: Although Ethiopia has more than 78% of leukemia cases and a significant burden of the disease, the survival of leukemia patients in the country is poorly recognized. The purpose of this study was to assess the survival and predictors of acute leukemia patients.Methods: A 5‐year retrospective cohort study was conducted including all acute Leukemia patients who visited Tikur Anbessa Specialized Hospital between January 2015 and December 2019. Data were retrieved from patient's medical records between March and April 2020. Using SPSS version 25, the Kaplan–Meier curve and Cox regression models were employed to analyze the data.Results: A total of 119 patients with acute leukemia were retrospectively evaluated for 60 months, having 196 person‐years of risk. About 46 deaths (38.7%) were recorded over the follow‐up period, giving a mortality incidence rate of 23.5 (95% CL:18–52) per 100 person‐years. The median survival time was 35 months (95% CI, 28.3–41.7). At 60 months of follow‐up, the predicted overall survival rate after diagnosis for acute leukemia was 21%. The adjusted hazard ratio for acute leukemia subtypes (aHR:4.9, 95% CI:2.3–10.4), history of relapse (aHR:3.9, 95% CI:1.0–7.9), participant age (aHR:1.25, 95% CI:1–1.75), hepatomegaly (aHR:2.7, 95% CI:1.36–5.36), and splenomegaly (aHR:2.29, 95% CI:1.2–4.4).Conclusion: The 5‐year overall survival rate was found to be 21%. The finding was remarkably lower than other published reports. Survival among acute leukemia patients was significantly associated with older age, history of relapse, hepatomegaly, splenomegaly, as well as certain subtypes. Therefore, improving early detection and initiation of treatment for all acute leukemia patients is necessary in order to improve patient's survival status.
- 2 October 2023
- Published by Wiley in Cancer Reports
- Vol. 6 (10) , e1890
Open AccessSurvival and predictors of mortality among acute leukemia patients on follow‐up in Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia: A 5‐year retrospective cohort study
Background: Although Ethiopia has more than 78% of leukemia cases and a significant burden of the disease, the survival of leukemia patients in the country is poorly recognized. The purpose of this study was to assess the survival and predictors of acute leukemia patients.Methods: A 5‐year retrospective cohort study was conducted including all acute Leukemia patients who visited Tikur Anbessa Specialized Hospital between January 2015 and December 2019. Data were retrieved from patient's medical records between March and April 2020. Using SPSS version 25, the Kaplan–Meier curve and Cox regression models were employed to analyze the data.Results: A total of 119 patients with acute leukemia were retrospectively evaluated for 60 months, having 196 person‐years of risk. About 46 deaths (38.7%) were recorded over the follow‐up period, giving a mortality incidence rate of 23.5 (95% CL:18–52) per 100 person‐years. The median survival time was 35 months (95% CI, 28.3–41.7). At 60 months of follow‐up, the predicted overall survival rate after diagnosis for acute leukemia was 21%. The adjusted hazard ratio for acute leukemia subtypes (aHR:4.9, 95% CI:2.3–10.4), history of relapse (aHR:3.9, 95% CI:1.0–7.9), participant age (aHR:1.25, 95% CI:1–1.75), hepatomegaly (aHR:2.7, 95% CI:1.36–5.36), and splenomegaly (aHR:2.29, 95% CI:1.2–4.4).Conclusion: The 5‐year overall survival rate was found to be 21%. The finding was remarkably lower than other published reports. Survival among acute leukemia patients was significantly associated with older age, history of relapse, hepatomegaly, splenomegaly, as well as certain subtypes. Therefore, improving early detection and initiation of treatment for all acute leukemia patients is necessary in order to improve patient's survival status.